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ABSTRACT
 
Esomeprazole is a BCS 11 compound, proton pump 
inhibitor used in the treatment of gastric, duodenal 
ulcer. The half-life of the drug is 4 hour. The drug has 
poor stability in acidic condition of the stomach. So, it 
is formulated into small sized and efficient carriers: 
the microspheres. To improve their residence time, 
bioadhesive characteristics can be coupled to develop 
mucoadhesive microspheres. Mucoadhesive 
microspheres are extensively used in targeted drug 
delivery due to their advantages like efficient 
absorption and improved bioavailability of the drugs 
and a much more intimate contact with the mucus 
layer, controlled and sustained release of drug from 
dosage form and exact targeting of drugs to the 
absorption site. Coating by enteric polymers will help 
to target the drug action in the intestine, particularly 
into the ileum region. Microsphere in conventional 
tablet will have disadvantages like it needs frequency 
of administration. Osmotic tablet will provide drug 
release independent of pH, but having the expense of 
complicated laser drilling. The main advantages of 
controlled porosity osmotic pump (CPOP) are reduced 
stomach irritation, no complicated laser-drilling 
procedures are followed. 
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INTRODUCTION 
Gastric and duodenal ulcer or peptic ulcer 
disease (PUD), Zollinger-Ellison 
Syndrome (ZE) and gastro oesophageal 
reflux disease (GRD) are upper 
gastrointestinal disorders sharing a 
common abnormality: too much acid and 
pepsin activity for the degree of local 
tissue resistance. Hydrolytic and 
proteolytic digestion of the exposed 
mucosa occurs, followed by inflammation, 
necrosis and ulceration. The primary class 
of drugs used for gastric acid suppression 
is the proton pump inhibitors, omeprazole, 
lansoprazole, pantoprazole, rabeprazole 
and esomeprazole [1]. Other class of drugs 
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like H2 receptor blockers cimetidine, 
famotidine, nizatidine, and ranitidine are 
also used for this purpose, but are now 
more widely used for maintenance therapy 
after treatment with the proton pump 
inhibitors [2-5]. The proton pump 
inhibitors works by block the secretion of 
gastric acid by the gastric parietal cells. 
The extent of inhibition of acid secretion is 
directly relates to its dose. In some cases, 
gastric acid secretion is completely 
blocked for over 24 hours on a single dose. 
In addition to their role in the treatment of 
gastric ulcers, they are used to treat 
syndromes of excessive acid secretion 
(Zollinger-Ellison Syndrome) and 
gastroesophageal reflux disease (GERD). 
Omeprazole is a racemic mixture and 
esomeprazole is the s-enantiomer of 
omeprazole [6]. It’s having less first pass 
metabolism than omeprazole so gives 
higher bioavailability, more effective and 
longer lasting with blockage over 24hours 
dosage. Produces increased antimicrobial 
activity against H.pylori organism than 
omeprazole. Esomeprazole is irreversibly 
bound to proton pump inhibitors, less 
pronounced inter individual variation in 
gastric pH and might be expected to 
produce a more consistent clinical 
response. But it is an acid-liable drug 
unstable in gastric pH, hence it is 
incorporated within a polymer matrix to 
protect drug from low pH of the stomach 
[7-10]. 
 
Microencapsulation 
It is the process in which tiny particles or 
droplets are coated to give small capsules 
of many useful properties like 
incorporation of food ingredients, 
enzymes, cells or other materials of micro 
metric scale. Microencapsulation can also 
be used to enclose solids, liquids, or gases 
inside a micrometric wall made of hard or 
soft soluble film, so that we can reduce 
dosing frequency and there by prevents the 
degradation of pharmaceuticals [11]. 
Preparation of Microspheres 
Different microencapsulation techniques 
used are as follows: 
 Emulsion Solvent Evaporation 
Technique 
 Emulsion Cross Linking Method 
 Coacervation Method 
 Spray Drying Technique 
 Emulsion-Solvent Diffusion Technique 
 Multiple Emulsion Method 
 Ionic Gelation Method 
 Quasi Emulsion Solvent Diffusion 
 
Although all methods offer many 
significant advantages, it is only for the 
sake of some drawbacks. Some of the 
important drawbacks of these techniques 
include non-uniform coating, non-
reproducible release kinetics and more 
importantly, the use of more or less harsh 
conditions in the formulation process 
which limits the many substances such as 
proteins, enzymes and live cells etc. as 
core materials for encapsulation. This 
problem can be overcome by applying a 
technique is based on principle of 
Ionotropic gelation (polyelectrolyte 
complexation). This involves the 
interaction of a cation (or an anion) with 
an ionic polymer to generate a highly cross 
linked structure with the ability to sustain 
the drug release by holding the drug over a 
period of time. It is very simple method 
and it needs only mild laboratory condition 
for their formation [12]. 
 
Double Walled Microspheres 
Traditional microsphere formed by a 
single polymer have drawbacks such as 
high initial burst, low encapsulation 
efficiency especially for highly water 
soluble drugs, inability to lend themselves 
to pulsatile or zero order release and lack 
of sustained release for periods during 
periodic therapy. By exploiting the 
phenomenon of phase separation between 
two immiscible polymers dissolved in a 
mutual solvent, a double-walled 
microsphere could be manufactured with 
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the second polymer coating the 
polymer/drug matrix. The limitation of 
microspheres made of a single polymer 
encapsulating drugs includes an initial 
burst caused by the release of the drug 
trapped on the surface during the 
encapsulation process and a progressively 
slower release rate. Therefore, 
microspheres made with a two-layered 
structure may have certain advantages over 
their counterparts made from single 
polymers [13]. 
 
Formulation of Double Walled 
Microspheres 
Solvent Evaporation Method 
Two polymers are dissolved in a volatile 
organic solvent such as dichloromethane. 
It is then added into aqueous solution 
containing surfactant and stirred. As the 
polymers become more concentrated, they 
begin to phase separate and form the core 
shell structure Double walled 
microspheres [14]. 
 
Oil-In-Water (O/W) Method 
It can produce Double-wall microspheres 
(DWMS) with core and shell polymers at 
their thermodynamically stable 
configurations according to the spreading 
coefficient theory [15-18]. 
 
Oil -In-Oil Oil-In-Water (O/O/W) Method 
It was used for producing double walled 
microsphere for research purpose. 
 
Layer–by-layer Deposition Method 
This method involves the deposition of 
layer-by-layer film components onto the 
outer surface of colloidal particles that are 
removed by physical or chemical means. 
 
For these methods, the control of double 
walled microsphere and MC dimensions 
such as outer diameter and shell thickness 
is typically poor. The emulsion method 
can produce Double walled microsphere 
with relatively broad size distribution and 
the polymer orientation for core and shell 
may change during fabrication. For layer-
by-layer coating, the diameter and shell 
coating can be very uniform, but these 
dimensions are controlled by templates. 
Besides, this method possesses limitations 
when generating thick layers or 
encapsulating a liquid core. 
 
Osmotic Drug Delivery System 
Most probably the conventional drug 
delivery system provides an immediate 
release of drug without any control over 
the release of the drug and it is difficult to 
maintain effective drug concentration at 
the target site for a longer period of time. 
Hence, to avoid the shortcomings there is 
the development of various controlled drug 
delivery systems. Among these, osmotic 
drug delivery systems (ODDS) utilizes the 
osmotic pressure created by osmogens is 
used as driving force for these systems to 
release the drug in a controlled manner and 
can be used for both oral and implantation. 
The drug release is independent of the pH 
and thermodynamics of dissolution 
medium. The osmotic drug delivery 
system offers many advantages over other 
controlled drug delivery systems, such as 
easy formulation procedure and simple 
operation, improved patient compliance by 
reducing the dosing frequency and 
prolonged therapeutic effect with uniform 
blood concentration. Controlled porosity 
osmotic pump (CPOP) based drug delivery 
system contains active ingredient, 
osmogens, semi permeable membrane, 
channelling agent and water soluble 
additives. In this system, when water 
comes in contact with water soluble 
additives it results in an in situ formation 
of a Microporous membrane. The main 
driving force for the release of drug is 
osmotic pressure. Osmogens maintain 
concentration gradient across the 
membrane [19]. 
 
CONCLUSION 
Since esomeprazole is an acid liable drug 
encapsulation technique will protect the 
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drug from an acidic condition of the 
stomach. Coating by enteric polymers 
make them as double walled and can target 
the drug action into the intestine. These 
microspheres is compressed with osmotic 
agent and other diluent will forms tablet 
that release drug by process of osmosis. 
Finally, coating of the tablet by pore 
forming agents produces controlled 
porosity osmotic pump tablet. Controlled 
delivery of esomeprazole microsphere 
incorporated in an osmotic tablet 
progressively deliver a measurable, 
reproducible amount of drug over a 
prolonged period could exhibit improved 
therapeutic effect, quality character of 
formulation and patient compliance. 
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